BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27422621)

  • 1. OpenGeneMed: a portable, flexible and customizable informatics hub for the coordination of next-generation sequencing studies in support of precision medicine trials.
    Palmisano A; Zhao Y; Li MC; Polley EC; Simon RM
    Brief Bioinform; 2017 Sep; 18(5):723-734. PubMed ID: 27422621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GeneMed: An Informatics Hub for the Coordination of Next-Generation Sequencing Studies that Support Precision Oncology Clinical Trials.
    Zhao Y; Polley EC; Li MC; Lih CJ; Palmisano A; Sims DJ; Rubinstein LV; Conley BA; Chen AP; Williams PM; Kummar S; Doroshow JH; Simon RM
    Cancer Inform; 2015; 14(Suppl 2):45-55. PubMed ID: 25861217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.
    Coyne GO; Takebe N; Chen AP
    Curr Probl Cancer; 2017; 41(3):182-193. PubMed ID: 28372823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. svist4get: a simple visualization tool for genomic tracks from sequencing experiments.
    Egorov AA; Sakharova EA; Anisimova AS; Dmitriev SE; Gladyshev VN; Kulakovskiy IV
    BMC Bioinformatics; 2019 Mar; 20(1):113. PubMed ID: 30841857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMITH: a LIMS for handling next-generation sequencing workflows.
    Venco F; Vaskin Y; Ceol A; Muller H
    BMC Bioinformatics; 2014; 15 Suppl 14(Suppl 14):S3. PubMed ID: 25471934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The possibility of clinical sequencing in the management of cancer.
    Kou T; Kanai M; Matsumoto S; Okuno Y; Muto M
    Jpn J Clin Oncol; 2016 May; 46(5):399-406. PubMed ID: 26917600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute-Designated Cancer Program.
    Mantripragada KC; Olszewski AJ; Schumacher A; Perez K; Birnbaum A; Reagan JL; Mega A; Khurshid H; Bartley C; Lombardo A; Rossiter R; Papa A; Bakalarski P; Safran H
    J Oncol Pract; 2016 Apr; 12(4):e396-404. PubMed ID: 26907448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomics-Enabled Precision Medicine for Cancer.
    Roos A; Byron SA
    Cancer Treat Res; 2019; 178():137-169. PubMed ID: 31209844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enabling precision medicine via standard communication of HTS provenance, analysis, and results.
    Alterovitz G; Dean D; Goble C; Crusoe MR; Soiland-Reyes S; Bell A; Hayes A; Suresh A; Purkayastha A; King CH; Taylor D; Johanson E; Thompson EE; Donaldson E; Morizono H; Tsang H; Vora JK; Goecks J; Yao J; Almeida JS; Keeney J; Addepalli K; Krampis K; Smith KM; Guo L; Walderhaug M; Schito M; Ezewudo M; Guimera N; Walsh P; Kahsay R; Gottipati S; Rodwell TC; Bloom T; Lai Y; Simonyan V; Mazumder R
    PLoS Biol; 2018 Dec; 16(12):e3000099. PubMed ID: 30596645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D3Oncoprint: Stand-Alone Software to Visualize and Dynamically Explore Annotated Genomic Mutation Files.
    Palmisano A; Zhao Y; Simon RM
    JCO Clin Cancer Inform; 2018 Dec; 2():1-9. PubMed ID: 30652557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing Next-Generation Sequencing-Guided Cancer Care Through Cognitive Computing.
    Patel NM; Michelini VV; Snell JM; Balu S; Hoyle AP; Parker JS; Hayward MC; Eberhard DA; Salazar AH; McNeillie P; Xu J; Huettner CS; Koyama T; Utro F; Rhrissorrakrai K; Norel R; Bilal E; Royyuru A; Parida L; Earp HS; Grilley-Olson JE; Hayes DN; Harvey SJ; Sharpless NE; Kim WY
    Oncologist; 2018 Feb; 23(2):179-185. PubMed ID: 29158372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards.
    Perera-Bel J; Hutter B; Heining C; Bleckmann A; Fröhlich M; Fröhling S; Glimm H; Brors B; Beißbarth T
    Genome Med; 2018 Mar; 10(1):18. PubMed ID: 29544535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WHATIF: An open-source desktop application for extraction and management of the incidental findings from next-generation sequencing variant data.
    Ye Z; Kadolph C; Strenn R; Wall D; McPherson E; Lin S
    Comput Biol Med; 2016 Jan; 68():165-9. PubMed ID: 25890833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT Trial.
    Lih CJ; Sims DJ; Harrington RD; Polley EC; Zhao Y; Mehaffey MG; Forbes TD; Das B; Walsh WD; Datta V; Harper KN; Bouk CH; Rubinstein LV; Simon RM; Conley BA; Chen AP; Kummar S; Doroshow JH; Williams PM
    J Mol Diagn; 2016 Jan; 18(1):51-67. PubMed ID: 26602013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-generation sequencing: from conventional applications to breakthrough genomic analyses and precision oncology.
    Ziogas DE; Kyrochristos ID; Roukos DH
    Expert Rev Med Devices; 2018 Jan; 15(1):1-3. PubMed ID: 29284319
    [No Abstract]   [Full Text] [Related]  

  • 17. DIVIS: Integrated and Customizable Pipeline for Cancer Genome Sequencing Analysis and Interpretation.
    He X; Zhang Y; Yuan D; Han X; He J; Duan X; Liu S; Wang X; Niu B
    Front Oncol; 2021; 11():672597. PubMed ID: 34168993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations of developing an NGS assay for clinical applications in precision oncology: The NCI-MATCH NGS assay experience.
    Lih CJ; Takebe N
    Curr Probl Cancer; 2017; 41(3):201-211. PubMed ID: 28625332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.
    Syn NL; Yong WP; Goh BC; Lee SC
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):911-22. PubMed ID: 27249175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized Oncology Suite: integrating next-generation sequencing data and whole-slide bioimages.
    Dander A; Baldauf M; Sperk M; Pabinger S; Hiltpolt B; Trajanoski Z
    BMC Bioinformatics; 2014 Sep; 15(1):306. PubMed ID: 25230706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.